Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
3.
J Vasc Access ; 21(4): 536-538, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-232756

ABSTRACT

The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'.


Subject(s)
Arteriovenous Shunt, Surgical , Betacoronavirus/pathogenicity , Catheterization, Central Venous , Coronavirus Infections/prevention & control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Kidney Diseases/therapy , Occupational Exposure/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Renal Dialysis , Arteriovenous Shunt, Surgical/adverse effects , COVID-19 , Catheterization, Central Venous/adverse effects , Clinical Decision-Making , Coronavirus Infections/diagnosis , Coronavirus Infections/transmission , Coronavirus Infections/virology , Humans , Kidney Diseases/diagnosis , Occupational Exposure/adverse effects , Occupational Health , Patient Safety , Patient Selection , Pneumonia, Viral/diagnosis , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , Renal Dialysis/adverse effects , Risk Assessment , Risk Factors , SARS-CoV-2 , Time-to-Treatment , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL